key: cord-0736631-mmstb6aq
authors: Hausdorff, William P.; Flores, Jorge
title: Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652)
date: 2021-04-02
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.03.086
sha: 194288fc51b2f5e520e291e42f9b4ac92df0847e
doc_id: 736631
cord_uid: mmstb6aq

nan

Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652) Prof Bauer's letter highlights the paramount role of high affinity IgG against the receptor binding domain of the S protein of SARS-CoV-2 in the prevention of infection. It suggests that natural infection doesn't elicit sufficiently high levels of high affinity IgG in most individuals to last for several months post-exposure and provide protection against re-infection, and concludes that this would alter "the potential risk" for volunteers in a human challenge (CHIM) study involving low dose and/or oral administration of SARS-CoV-2.

While we found this letter to be interesting and share the belief that widespread vaccination is ultimately the best way to stop the present pandemic, we are a bit puzzled as to the relevance of these findings to our article (Hausdorff and Flores, 2021) . We had highlighted the importance of having as the primary public health goal the prevention of serious COVID disease, as opposed to prevention of every SARS-CoV-2 infection. Accordingly, the major hypothesis to be tested in the CHIM we described is whether low dose and/or oral exposure would lead to asymptomatic infection or, at most, very mild disease. If so, then the necessity of draconian non-pharmaceutical interventions designed to eliminate all possible exposure to the virus might be revisited. We further speculated that such exposure might protect against serious disease in participants upon reinfection, but didn't consider the prospect, which we agree is unlikely, that it could induce sterilizing immunity or protection against low level infection. Protection against either infection or disease, incidentally, would influence the potential benefit, not risk, of participation in the study.

Finally, though the letter focuses on high levels of high affinity IgG in prevention of infection, we note that one of the authors cited (Khatri et al., 2020) is more centered on the value of high affinity IgA. A more recent study (McMahan et al., 2021) suggests a role for cellular immunity in the context of waning or suboptimal levels of antibodies, as macaques with only modest levels of antibodies following an initial SARS-CoV-2 infection were able to fend off reinfection as long as their CD8+ T cells remained undepleted. In any case, we would suggest that neither the immunological mechanisms necessary to protect against infection by SARS-CoV-2, nor the nature of the viral exposure sufficient to infect in the first place, are qualitatively or quantitatively identical to those involved in development of severe COVID.

Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19

Blocking of the high-affinity interaction-synapse between SARS CoV-2 spike and human ACE2 proteins likely requires multiple high-affinity antibodies: an immune perspective

Correlates of protection against SARS-CoV-2 in rhesus macaques

The authors declare they have no financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work.

None.

Not applicable.